714 related articles for article (PubMed ID: 8871677)
41. Analysis of action mechanism of lymphotoxin in prevention of cyclophosphamide-induced diabetes in NOD mice.
Takahashi K; Satoh J; Sagara M; Zhu XP; Muto G; Muto Y; Fukuzawa M; Nishimura S; Miyaguchi S; Toyata T
J Autoimmun; 1995 Jun; 8(3):335-46. PubMed ID: 7575995
[TBL] [Abstract][Full Text] [Related]
42. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
De Aizpurua HJ; French MB; Chosich N; Harrison LC
J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856
[TBL] [Abstract][Full Text] [Related]
43. T cells with multiple fine specificities are used by non-obese diabetic (NOD) mice in the response to GAD(524-543).
Quinn A; Sercarz EE
J Autoimmun; 1996 Jun; 9(3):365-70. PubMed ID: 8816972
[TBL] [Abstract][Full Text] [Related]
44. Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes.
Pankewycz O; Strom TB; Rubin-Kelley VE
Eur J Immunol; 1991 Apr; 21(4):873-9. PubMed ID: 1902177
[TBL] [Abstract][Full Text] [Related]
45. Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes.
Bergerot I; Fabien N; Maguer V; Thivolet C
J Autoimmun; 1994 Oct; 7(5):655-63. PubMed ID: 7840857
[TBL] [Abstract][Full Text] [Related]
46. High density insulin receptor-positive T lymphocytes from nonobese diabetic mice transfer insulitis and diabetes.
McInerney MF; Flynn JC; Goldblatt PJ; Najjar SM; Sherwin RS; Janeway CA
J Immunol; 1996 Oct; 157(8):3716-26. PubMed ID: 8871675
[TBL] [Abstract][Full Text] [Related]
47. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
[TBL] [Abstract][Full Text] [Related]
48. Islet-specific T cell clones transfer diabetes to nonobese diabetic (NOD) F1 mice.
Peterson JD; Pike B; McDuffie M; Haskins K
J Immunol; 1994 Sep; 153(6):2800-6. PubMed ID: 8077683
[TBL] [Abstract][Full Text] [Related]
49. T cell vaccination against autoimmune diabetes in nonobese diabetic mice.
Formby B; Shao T
Ann Clin Lab Sci; 1993; 23(2):137-47. PubMed ID: 8096128
[TBL] [Abstract][Full Text] [Related]
50. The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus.
Wang B; Gonzalez A; Benoist C; Mathis D
Eur J Immunol; 1996 Aug; 26(8):1762-9. PubMed ID: 8765018
[TBL] [Abstract][Full Text] [Related]
51. Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism.
Gong Z; Pan L; Le Y; Liu Q; Zhou M; Xing W; Zhuo R; Wang S; Guo J
Vaccine; 2010 May; 28(24):4052-8. PubMed ID: 20406664
[TBL] [Abstract][Full Text] [Related]
52. Prevention of autoimmune insulin-dependent diabetes in non-obese diabetic mice by anti-LFA-1 and anti-ICAM-1 mAb.
Hasegawa Y; Yokono K; Taki T; Amano K; Tominaga Y; Yoneda R; Yagi N; Maeda S; Yagita H; Okumura K
Int Immunol; 1994 Jun; 6(6):831-8. PubMed ID: 7916204
[TBL] [Abstract][Full Text] [Related]
53. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice.
Li H; Kaufman CL; Boggs SS; Johnson PC; Patrene KD; Ildstad ST
J Immunol; 1996 Jan; 156(1):380-8. PubMed ID: 8598488
[TBL] [Abstract][Full Text] [Related]
54. Paradoxical lessening of autoimmune processes in non-obese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus.
Hermitte L; Vialettes B; Naquet P; Atlan C; Payan MJ; Vague P
Eur J Immunol; 1990 Jun; 20(6):1297-303. PubMed ID: 2164479
[TBL] [Abstract][Full Text] [Related]
55. Administering glutamic acid decarboxylase to NOD mice prevents diabetes.
Tisch R; Yang XD; Liblau RS; McDevitt HO
J Autoimmun; 1994 Dec; 7(6):845-50. PubMed ID: 7888040
[TBL] [Abstract][Full Text] [Related]
56. Prevention of reovirus type 2-induced diabetes-like syndrome in DBA/1 suckling mice by treatment with antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1.
Hayashi T; Yamamoto S; Onodera T
Int J Exp Pathol; 1995 Dec; 76(6):403-9. PubMed ID: 8652360
[TBL] [Abstract][Full Text] [Related]
57. Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study.
Miyazaki A; Hanafusa T; Yamada K; Miyagawa J; Fujino-Kurihara H; Nakajima H; Nonaka K; Tarui S
Clin Exp Immunol; 1985 Jun; 60(3):622-30. PubMed ID: 3160515
[TBL] [Abstract][Full Text] [Related]
58. Long-term reversal of established autoimmunity upon transient blockade of the LFA-1/intercellular adhesion molecule-1 pathway.
Bertry-Coussot L; Lucas B; Danel C; Halbwachs-Mecarelli L; Bach JF; Chatenoud L; Lemarchand P
J Immunol; 2002 Apr; 168(7):3641-8. PubMed ID: 11907130
[TBL] [Abstract][Full Text] [Related]
59. Splenocytes from non-obese-diabetic mice binding to xenogeneic beta-cells in vitro: an early marker of cell-mediated immunity.
Martignat L; Feve B; Charbonnel B; Sai P
Diabete Metab; 1993; 19(6):566-74. PubMed ID: 8026608
[TBL] [Abstract][Full Text] [Related]
60. Prevention of diabetes but not insulitis in NOD mice injected with antibody to CD4.
Hayward AR; Shriber M; Cooke A; Waldmann H
J Autoimmun; 1993 Jun; 6(3):301-10. PubMed ID: 8104407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
